Related Experiment Video
Updated: Jul 8, 2026
10:46
A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
Published on: September 13, 2022
Natriuretic peptide receptor a as a novel anticancer target
Xiaoyuan Kong1, Xiaoqin Wang, Weidong Xu
1Joy McCann Culverhouse Airway Disease and Nanomedicine Research Center, Allergy and Immunology Division, Department of Internal Medicine, University of South Florida College of Medicine, Tampa, FL 33612, USA.
Cancer Research
|January 4, 2008
Summary
Natriuretic peptide receptor A (NPRA) signaling drives tumor growth. Inhibiting NPRA in mice reduced lung, skin, and ovarian cancers, suggesting NPRA as a novel cancer therapy target.
Area of Science:
- Oncology
- Molecular Biology
- Cardiovascular Research
Background:
- Natriuretic peptide receptor A (NPRA) is expressed in cancer cells.
- The precise role of NPRA signaling in tumor development is not fully understood.
Purpose of the Study:
- To investigate the direct role of NPRA signaling in tumorigenesis.
- To explore NPRA as a potential therapeutic target for cancer treatment.
Main Methods:
- Utilized NPRA-deficient mice to assess tumor development.
- Employed nanoparticle-formulated interfering RNA to target NPRA in melanoma.
- Investigated the effects of NP73-102 peptide on tumor metastasis and growth.
- Analyzed molecular markers including nuclear factor-kappaB and retinoblastoma protein.
Main Results:
- NPRA deficiency significantly reduced tumor incidence in multiple cancer models (lung, skin, ovarian).
- Interfering RNA targeting NPRA and NP73-102 peptide administration suppressed tumor growth and metastasis.
- NPRA inhibition led to nuclear factor-kappaB inactivation and retinoblastoma protein upregulation.
- Vascular endothelial growth factor expression was decreased in NPRA-deficient lungs.
Conclusions:
- NPRA signaling is crucial for tumor growth and progression.
- Targeting NPRA demonstrates significant antitumor activity.
- NPRA plays a role in tumor angiogenesis, making it a promising target for novel cancer therapies.
Related Concept Videos
01:27Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:38Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates these...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...